Dr. Paul Adams
Dr. Paul Adams, is a Professor of Medicine and Chief of Gastroenterology at the University of Western Ontario, in London, Ontario. Dr. Adams has been working in the field of hemochromatosis and iron overload since 1977. He graduated from medical school at Queens University (Kingston, Ontario) in 1980 and completed internal medicine training in Toronto and New York (Mount Sinai). He was a Principal Investigator of the NIH sponsored HEIRS study which has screened 101,168 people for iron overload. He has studied many aspects of iron overload, including genotypic-phenotypic correlations, cost-effectiveness of screening, psychosocial impact of testing, and new genetic polymorphisms of the HFE gene. He a practicing gastroenterologist at University Hospital in London, Ontario.
Dr. Henri Menard
MD, FRCP (C)
Dr. Ménard is a former Professor of Medicine at McGill University and Master of Rheumatology of the Pan-American League of Associations of Rheumatology. His research interests and contributions focused on autoantigens and autoantibodies as biomarkers of systemic autoimmune rheumatic diseases, notably Rheumatoid Arthritis. He became interested in arthritis as an early alert for hemochromatosis. Dr. Ménard found that arthritis is observed not only in people carrying the major mutation associated with too much iron but also in those carrying the so-called “silent” or minor mutation, without easily measurable excess iron.
Dr. Robert Turner
Dr. Turner is a Clinical Professor of Medical Oncology at the University of Alberta Cross Cancer Institute.